Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clonal Cytopenia of Undetermined Significance”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Early research (Phase 1)Study completedNCT05102370
What this trial is testing

Enasidenib in People With Clonal Cytopenia of Undetermined Significance

Who this might be right for
Clonal Cytopenia of Undetermined SignificanceCCUS Clonal Cytopenia of Undetermined Significance
Memorial Sloan Kettering Cancer Center 4
Not applicableNot Yet RecruitingNCT07313059
What this trial is testing

CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research

Who this might be right for
Clonal HematopoiesisCCUS Clonal Cytopenia of Undetermined SignificanceHematologic Disease and Disorders
Clinical Hub for Interventional Research (CHOIR) 100
Testing effectiveness (Phase 2)Looking for participantsNCT05483010
What this trial is testing

Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

Who this might be right for
Clonal Cytopenia of Undetermined SignificanceMyelodysplastic Syndromes
Washington University School of Medicine 16
Very early researchLooking for participantsNCT06802146
What this trial is testing

Early Intervention in High Risk CCUS

Who this might be right for
Clonal Cytopenia of Undetermined SignificanceCytopenia
Lachelle D. Weeks, MD, PhD 108
Testing effectiveness (Phase 2)Looking for participantsNCT06788691
What this trial is testing

Luspatercept for Clonal Cytopenias of Uncertain Significance

Who this might be right for
CCUS Clonal Cytopenia of Undetermined SignificanceAnemiaLeukopenia+2 more
Weill Medical College of Cornell University 50
Not applicableActive Not RecruitingNCT04902833
What this trial is testing

Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

Who this might be right for
Pyruvate Kinase DeficiencyPyruvate Kinase Deficiency AnemiaHereditary Hemolytic Anemia+8 more
Massachusetts General Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT04741945
What this trial is testing

Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS

Who this might be right for
PreleukemiaMyelodysplastic NeoplasmCytopenia+1 more
Kirsten Grønbæk 40
Not applicableLooking for participantsNCT02958462
What this trial is testing

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Who this might be right for
Myeloid MalignancyInherited Bone Marrow Failure SyndromeClonal Expansion+10 more
Mayo Clinic 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT03418038
What this trial is testing

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Who this might be right for
Clonal Cytopenia of Undetermined SignificanceHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Diffuse Large B-Cell Lymphoma+5 more
Mayo Clinic 80
Testing effectiveness (Phase 2)Looking for participantsNCT05641831
What this trial is testing

Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study

Who this might be right for
Clonal Cytopenia of Undetermined Significance
Uma Borate 110
Not applicableActive Not RecruitingNCT03682029
What this trial is testing

Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic Leukemia-1Cytopenia
Rigshospitalet, Denmark 109
Testing effectiveness (Phase 2)Looking for participantsNCT06240754
What this trial is testing

Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial

Who this might be right for
Clonal Cytopenia of Undetermined SignificanceCCUS Clonal Cytopenia of Undetermined Significance
Washington University School of Medicine 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05030441
What this trial is testing

Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1

Who this might be right for
Clonal Cytopenia of Undetermined Significance
Washington University School of Medicine 20
Not applicableEnrolling By InvitationNCT04428489
What this trial is testing

Follow-up Study of ICUS and CCUS Patients

Who this might be right for
Myelodysplastic Syndromes
The First Affiliated Hospital of Soochow University 300
Not applicableLooking for participantsNCT06295965
What this trial is testing

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+7 more
University of Washington 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT06566742
What this trial is testing

Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaClonal Cytopenia of Undetermined Significance
M.D. Anderson Cancer Center 15
Not applicableLooking for participantsNCT04102423
What this trial is testing

CHIP/CCUS Natural History Protocol

Who this might be right for
Clonal Hematopoiesis of Indeterminate PotentialClonal Cytopenia of Undetermined Significance
National Heart, Lung, and Blood Institute (NHLBI) 306
Testing effectiveness (Phase 2)Looking for participantsNCT06063486
What this trial is testing

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

Who this might be right for
Clonal Cytopenia of Undetermined SignificanceEssential ThrombocythemiaMyelodysplastic Syndrome+2 more
University of Southern California 30